Pharmaceutical Executive April 20, 2023
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
In two Pharma 2023 sessions, “Digital Health: Does Pharma Know its Role Yet?” and “Power Patient-Reported Outcomes through Digital Health Tools,” the reasons cited for pharma being involved in digital health were threefold: engage patients for the long-term journey with their conditions; keep health systems and physicians connected to their patients; and find patients who need higher efficacy treatments at the right time.
In the second session, Johannes Munding, director, patient experience design and solutions, neuroscience, Novartis, noted of digital health solutions that it’s a good idea to understand how a patient is doing in real-time, in the real-world, and shift away from current...